Submit
Contact Us
Submit
Products
Carterra LSA Instrument
Sensor Chips & Solutions
Kinetics Software
Epitope Analysis Software
AI, ML & In Silico Tools
Applications
Overview
High Throughput Kinetics
Epitope Binning
Quantitation
Antibody Epitope Mapping
Therapeutic Areas
Antibody Formats
Technology
Carterra LSA Technology
SPR Overview
Testimonials
Frequently Asked Questions
Resources
Application Notes
Webinars
Podcasts
White Papers
Peer-Reviewed Publications
Brochures
Posters
2019 Carterra Symposia
About Us
Overview
Management Team
Board of Directors
Testimonials
Careers
News
Blog
Events
Contact Us
Support
Inquiries
Customer Login
Application Training & Support
Store
Resource Center
Learn About Carterra and the LSA Platform
Peer-Reviewed Publication
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Poster
Increasing DNA Encoded Library Screening Resolution Using HT-SPR
Application Note
High resolution FcRn IC
50
potency measurements using the Carterra
®
LSA
®
platform
Application Note
Profiling antibody polyreactivity and polyspecificity using HT-SPR on the Carterra
®
LSA
®
Webinar
The Transcendence of HT-SPR Technology Across Discovery Platforms and its Impact on Time-to-Clinic
Webinar
AlphaLISA and HT-SPR together can help you better understand FcRn biology
Peer-Reviewed Publication
A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies – January 24, 2022
Peer-Reviewed Publication
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries – December 30, 2021
Peer-Reviewed Publication
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries – December 1, 2021
Webinar
Exploring Multicomponent COVID-19 Mutant Variant Analysis of Immunity Indicators in Human Serum
Webinar
HT-SPR Technology to Inform and Accelerate the Antibody Discovery Process
Webinar
Bispecific Antibodies Potently Neutralize SARS-CoV-2 Variants of Concern
Webinar
The Transcendence of HT-SPR Technology Across Discovery Platforms and its Impact on Time-to-Clinic
Peer-Reviewed Publication
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study – September 23, 2021
1
2